COMMUNIQUÉS West-GlobeNewswire

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
25/04/2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Media Advisory - 2025 Virtual Reality Expo: Accelerating Innovation in Healthcare
25/04/2025
MONTREAL, April 25, 2025 (GLOBE NEWSWIRE) -- Media representatives are invited to the 2025 edition of the VR Expo: Accelerating Innovation in Health Care , an immersive event that explores the potential of virtual [...]
Avis aux médias - Exposition Réalité Virtuelle 2025 : Accélérer l'innovation en matière de soins de santé
25/04/2025
MONTRÉAL, 25 avr. 2025 (GLOBE NEWSWIRE) -- Les représentants des médias sont cordialement invités à l’édition 2025 de la RV Expo : accélérer l’innovation en matière de soins de santé, un événement immersif qui explore [...]
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
25/04/2025
Advanced Spatial Quinomics Study Reveals Novel Insights into the Therapeutic Impact of BPM31510, Being Studied as a Potential Treatment for Primary CoQ10 Deficiency and Other Mitochondrial Diseases BOSTON, April 25, [...]
CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.
25/04/2025
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“ CPOINT ”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“ Juno ”) acquired 1,875,000 common shares (the “ Common [...]
Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda
25/04/2025
April 25, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM [...]
A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States
25/04/2025
LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an [...]
Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia
25/04/2025
First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea. Novel IVL technology designed to deliver calcium fragmentation for treatment [...]
Best Thermogenic Fat Burner Supplements 2025: Top Fat Burning Pills for Weight Loss From PhenQ
25/04/2025
Clinically-backed thermogenic fat burners accelerate metabolism, ignite fat loss, and curb appetite—PhenQ leads 2025’s top fat-burning supplements for men and women aiming for sustainable weight loss results. NEW YORK, [...]
TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease
25/04/2025
The first a approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis, 1 , 2 , 3 , 4 , 5 guselkumab showed statistically higher rates of endoscopic [...]
Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease
25/04/2025
ORION CORPORATION PRESS RELEASE 25 APRIL 2025 at 9.00 EEST Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“ [...]
Vistin Pharma ASA: First quarter 2025 financial results
25/04/2025
Oslo, Norway, 25 th of April 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in Q1 2024. Sales [...]
SYNC Sunlight Loophole Under Review: Unique Metabolism Boosting Formula to Burn Belly Fat Fast
25/04/2025
Disrupting the Weight Loss Plateau: New Clock Gene Supplement ‘SYNC’ Restores Metabolic Rhythm for Natural Fat-Burning & All-Day Energy Aurora, Colorado, April 25, 2025 (GLOBE NEWSWIRE) -- If you've ever felt like [...]
Okita Nail Fungus Light Under Review: Best At-Home Toenail Fungus Cleaning Light for Onychomycosis
25/04/2025
Discover How the Okita Nail Fungus Light Uses Red & Blue LED Therapy to Help Improve Nail Clarity at Home—A Drug-Free, Pain-Free Solution for Onychomycosis Sufferers Seeking Visible Results Wanchai, Hong Kong, April [...]
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
25/04/2025
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32% 1 CENTERSTONE is the first [...]
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
25/04/2025
Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for development in substance [...]
Champions for Change Celebrated at 2025 Helen Keller Achievement Awards
25/04/2025
Author Andrew Leland Breaks Down Misconceptions of People with Disabilities; Business Leader Thomas Wlodkowski Recognized for Bolstering Access to Media; Mattel Lauded for Blind Barbie’s Global Impact on Positive [...]
BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering
25/04/2025
PHILADELPHIA and VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
25/04/2025
HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]

Pages